Journal article
Antifungal therapeutic drug monitoring practices: results of an Emerging Infections Network survey
Open forum infectious diseases, Vol.10(9), ofad468
09/2023
DOI: 10.1093/ofid/ofad468
PMCID: PMC10533201
PMID: 37771852
Abstract
Abstract In a survey of 523 infectious disease specialists, a moderate-to-high percentage reported using any antifungal therapeutic drug monitoring (TDM) during itraconazole (72%), posaconazole (72%), and voriconazole (90%) treatment and low-to-moderate during prophylaxis (32%, 55%, and 65%, respectively). Long turnaround times for send-out TDM testing and logistical difficulties were frequent barriers.
Details
- Title: Subtitle
- Antifungal therapeutic drug monitoring practices: results of an Emerging Infections Network survey
- Creators
- Kaitlin Benedict - Centers for Disease Control and PreventionJeremy A W Gold - Centers for Disease Control and PreventionSusan E Beekmann - University of IowaPhilip M Polgreen - University of IowaMitsuru Toda - Centers for Disease Control and PreventionDallas J Smith - Centers for Disease Control and Prevention
- Resource Type
- Journal article
- Publication Details
- Open forum infectious diseases, Vol.10(9), ofad468
- DOI
- 10.1093/ofid/ofad468
- PMID
- 37771852
- PMCID
- PMC10533201
- NLM abbreviation
- Open Forum Infect Dis
- ISSN
- 2328-8957
- eISSN
- 2328-8957
- Grant note
- name: Cooperative Agreement, award: NU50 CK000574; DOI: 10.13039/100000030, name: Centers for Disease Control and Prevention
- Language
- English
- Electronic publication date
- 09/12/2023
- Date published
- 09/2023
- Academic Unit
- Infectious Diseases; Epidemiology; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9984463086102771
Metrics
17 Record Views